Preclinical mouse models for BRCA1-associated breast cancer

por Drost, R M, Jonkers, J
Publicado 2009

Mouse models in the era of large human tumour sequencing studies

por de Ruiter, J. R., Wessels, L. F. A., Jonkers, J.
Publicado 2018

Suppression of BRCA1 sensitizes cells to proteasome inhibitors

por Gu, Y, Bouwman, P, Greco, D, Saarela, J, Yadav, B, Jonkers, J, Kuznetsov, S G
Publicado 2014

FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer

por Gong, C, Fujino, K, Monteiro, L J, Gomes, A R, Drost, R, Davidson-Smith, H, Takeda, S, Khoo, U S, Jonkers, J, Sproul, D, Lam, E W-F
Publicado 2015

Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation

por van Miltenburg, M H A M, van Nimwegen, M J, Tijdens, I, Lalai, R, Kuiper, R, Klarenbeek, S, Schouten, P C, de Vries, A, Jonkers, J, van de Water, B
Publicado 2014

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

por Cruz, C, Castroviejo-Bermejo, M, Gutiérrez-Enríquez, S, Llop-Guevara, A, Ibrahim, Y H, Gris-Oliver, A, Bonache, S, Morancho, B, Bruna, A, Rueda, O M, Lai, Z, Polanska, U M, Jones, G N, Kristel, P, de Bustos, L, Guzman, M, Rodríguez, O, Grueso, J, Montalban, G, Caratú, G, Mancuso, F, Fasani, R, Jiménez, J, Howat, W J, Dougherty, B, Vivancos, A, Nuciforo, P, Serres-Créixams, X, Rubio, I T, Oaknin, A, Cadogan, E, Barrett, J C, Caldas, C, Baselga, J, Saura, C, Cortés, J, Arribas, J, Jonkers, J, Díez, O, O’Connor, M J, Balmaña, J, Serra, V
Publicado 2018